Microbiome-Based Body Fluid Identification

The human body is not a uniform host for microbes. Different anatomical sites vary enormously in oxygen tension, pH, temperature, nutrient availability, and immune surveillance. These differences select for distinct microbial communities, and the communities are stable enough over time and consistent enough across individuals to serve as body-site markers.

The vaginal microbiome is the most forensically exploited because its Lactobacillus dominance is genuinely unusual. No other body site maintains a consistently high-dominance Lactobacillus community. When 16S sequencing reveals a sample dominated by L. crispatus at 70 to 90% relative abundance, the fluid of origin is almost certainly vaginal or cervicovaginal. The exception is the roughly 20 to 40% of individuals with a Lactobacillus-sparse CST IV vaginal microbiome, whose vaginal fluid would be more ambiguous. Acknowledging this limitation is part of honest reporting.

The 16S rRNA gene is roughly 1,550 base pairs long in bacteria. It contains nine hypervariable regions (V1 through V9) flanked by conserved sequences. By designing primers against the conserved flanks, researchers amplify the hypervariable inserts from every bacterium in a sample simultaneously. Next-generation sequencing then reads millions of those amplicons in parallel, and bioinformatic tools classify each sequence to a taxon.

1. DNA extraction
   Total DNA is extracted from the stain. Bead-beating lysis is preferred to ensure thorough cell disruption of gram-positive bacteria with thick cell walls. Both human and microbial DNA are extracted together; downstream steps target the bacterial fraction via 16S amplification.
2. 16S amplicon PCR
   Universal primers targeting one or two hypervariable regions (most commonly V1-V2 or V3-V4 for forensic fluid work) are used to amplify the bacterial 16S locus. Indexed adapters are added in a second PCR step so multiple samples can be sequenced in a single multiplexed run.
3. Next-generation sequencing
   Illumina MiSeq or similar short-read platforms generate hundreds of thousands of reads per sample. Read quality is filtered and paired reads are merged if an overlapping strategy is used.
4. Bioinformatic classification
   Reads are grouped into ASVs using tools such as DADA2 or QIIME2, then classified against a curated 16S reference database (SILVA, Greengenes2). The output is a per-sample table of taxon relative abundances.
5. Fluid classification
   Machine-learning classifiers or rule-based thresholds (for example, Lactobacillus relative abundance above a trained cut-off = vaginal) assign a fluid-type call from the taxon table. Performance is typically reported as sensitivity and specificity per fluid type across a reference panel.

The argument for microbiome profiling as a forensic tool rests largely on its performance in scenarios where conventional markers fail. The physical basis for this advantage is straightforward: bacterial DNA is protected inside intact or partially intact cells with thick, protective cell walls, and the 16S target is short enough (the amplified hypervariable region is typically 250 to 500 bp) to survive moderate degradation. Proteins are more susceptible to enzymatic hydrolysis, and mRNA degrades via RNases and base hydrolysis from the moment the cell lyses.

Experimental comparisons on aged stains have found that 16S amplification succeeds at time points where p30 ELISA is negative and mRNA profiling yields no signal. Phipps and Tobe (2016) and subsequent groups reported positive 16S profiles from vaginal secretion stains aged six to twelve months under room-temperature storage, while conventional fluid ID tests were uninformative by two to four months. The advantage is clearest for stains on outdoor surfaces, which are subject to UV exposure and rainfall that destroy proteins and RNA faster than they destroy cell-wall-protected DNA.

Microbiome-based fluid identification introduces interpretive challenges absent from mRNA or protein assays. Understanding them is necessary for writing a forensically defensible report.

• Microbial transfer: microbes transfer between surfaces on contact, just as trace evidence does. Skin bacteria from hands deposit on objects. Oral bacteria aerosolise during speech and land on nearby surfaces. A surface with a high Lactobacillus signal does not guarantee that vaginal fluid was the only, or even the primary, source.
• Community state variation: approximately 20 to 30% of individuals have a CST IV vaginal microbiome with low Lactobacillus abundance and high diversity. Their vaginal fluid does not produce the typical high-Lactobacillus signature. A negative Lactobacillus signal does not exclude vaginal fluid from a CST IV donor.
• Environmental contamination: substrates are not sterile before a stain deposits. Environmental bacteria on cloth, soil, or outdoor surfaces will contribute reads to the 16S profile. Blank substrate controls must accompany every case sample.
• Mixture interpretation: a stain containing both vaginal fluid and semen will show a mixture of the two communities. Deconvolving mixtures at the microbial level is computationally tractable but requires validated deconvolution models that do not yet exist for most fluid combinations.
• No contributor identification: unlike DNA profiling, microbiome profiling cannot reliably identify a specific individual. It can answer which body fluid, but not whose body.

As of the mid-2020s, microbiome-based body fluid identification sits at the transition from research methodology to operational forensic tool. Several peer-reviewed studies have characterised fluid-specific microbial signatures and tested classification algorithms on reference panels of laboratory stains. A smaller number of publications have tested performance on casework-like aged or mixed stains.

The path to admissibility under US Daubert standards requires peer-reviewed publication of the method, a known or estimable error rate, general acceptance in the relevant scientific community, and that the testimony be based on sufficient facts or data. For microbiome fluid ID, the first criterion is increasingly met. The second (error rates across realistic case scenarios including aged, mixed, and CST IV samples) is still being established. The third, general scientific acceptance, is not yet there for operational casework use.

In Europe, ENFSI's evaluation framework asks whether a method has been validated to international standards such as ISO 18385 (for minimising human DNA contamination in forensic consumables) and ISO 17025. Microbiome methods have not yet been the subject of ENFSI guideline documents, reflecting their pre-operational status. Several national institutes, including the Netherlands Forensic Institute (NFI), have published research-grade validations that will likely form the basis of future operational guidelines.